The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Conditions
Glioblastoma · High-grade Glioma · Glioblastoma, IDH-wildtype · Glioblastoma, IDH-mutant · Glioblastoma Multiforme, Adult · Astrocytoma, Grade IV · Astrocytoma, Grade III · Astrocytoma, Malignant · Brain Neoplasms · Brain Neoplasm, Primary · Brain Neoplasms, Adult · Brain Neoplasm, Malignant
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, San Francisco (UCSF), San Francisco, California, United States
Contact: Study coordinator (Mitchel Berger, MD)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Brian Nahed, MD)University Hospitals Leuven, Leuven, Belgium
Contact: Study coordinator (Steven De Vleeschouwer, MD PhD)Universitätsklinikum Heidelberg, Heidelberg, Baden-Wurttemberg, Germany
Contact: Study coordinator (Christine Jungk, MD PhD)Contact: Study coordinator (Sandro Krieg, MD MBA)Technical University Munich, Munich, Bavaria, Germany
Contact: Study coordinator (Arthur Wagner, MD PhD)Erasmus Medical Center, Rotterdam, South Holland, Netherlands
Contact: Study coordinator (Jasper Gerritsen, MD PhD)Haaglanden Medical Centre, The Hague, South Holland, Netherlands
Contact: Study coordinator (Marike Broekman, MD PhD)Inselspital Universitätsspital Bern, Bern, Switzerland
Contact: Study coordinator (Philippe Schucht, MD PhD)
Study leads
Jasper Gerritsen, MD PhD
Principal Investigator
Erasmus Medical Center